SUMMARY Two contrasting cases of amiodarone hepatotoxicity are described. In one, perivenular collections of swollen cells, probably macrophages, with granular cytoplasm in an otherwise nearly normal liver were observed. Transmission electron microscopy showed that the cytoplasmic granularity was due to lysosomal bodies of various sizes. X-ray energy and wavelength spectroscopic analysis showed a high iodine content in these lysosomal bodies, good presumptive evidence of the presence of amiodarone or one of its metabolites. In the second case there was a micronodular cirrhosis, and similar granular cells also containing iodine were seen in the fibrous connective tissue. These cases seem to represent the very early and late stages of amiodarone hepatotoxicity. In a patient taking this drug aggregates of swollen granular cells may be a sensitive and histopathologically useful marker of early amiodarone toxicity.
Amiodarone is an iodinated amphophilic drug that has been available in Europe for the past 20 years; it was originally used for the treatment of angina.'
More recently the drug has been found to be very effective in the treatment of supraventricular tachyarrhythmias, including the Wolff-Parkinson-White syndrome, and in ventricular tachyarrhythmias. The drug is associated, however, with an increasingly recognised number of side effects.2 Amiodarone toxic effects are seen in the skin, lung, thyroid, peripheral nervous system, muscle, cornea and liver. 2 The drug accumulates in many organs, and some side effects, especially those affecting the skin and liver, seem to be dose related.2 Amiodarone toxicity is thought to be due to the accumulation of the drug in lysosomes where it combines with lysosomal membrane lipid (due to its amphophilic properties) to produce a secondary phospholipidosis.3 In the liver the phospholipidosis occurs in hepatocytes, Kupffer cells, bile duct epithelium and endothelial cells. 3 We report two cases of amiodarone hepatotoxicity. We believe that the histological features of our first case represent the first documentation of the earliest morphological changes of amiodarone hepatotoxicity and that those of the second represent the terminal stage of liver damage associated with amiodarone.
Accepted for publication 4 November 1986 Case reports CASE I A 64 year old man had a myocardial infarction in 1983, complicated by cardiac arrest and refractory ventricular arrhythmia. There was no relevant medical history and no history of excessive alcohol intake. He was given amiodarone 200 mg three times a day. Eight months later he complained of right upper quadrant discomfort, nausea, anorexia and weight loss, and he ran a low grade fever up to.38°C. His liver function tests yielded abnormal results, the aspartate aminotransferase (AST) activity being 54 IU/I (normal 10 to 40 IU/). His smooth muscle and mitochondrial antibodies were negative, the erythrocyte sedimentation rate was raised at 78mm/first hour, and the globulins raised at 37 g/l, mainly due to a rise in the a2 fraction. The antinuclear factor was negative. An ultrasound scan of the liver at that time was normal. He was loath to undergo liver biopsy. The possibility of a collagen disease was considered, and a trial of prednisolone (20mg/day) was given. There was initial improvement. The fever and symptoms of nausea The chambers and valves of the heart seemed to be normal. Histological examination of the heart showed patchy fibrosis of the myocardium with no evidence of past or recent infarction. The thyroid gland was normal on both macroscopic examination and histology.
Material and methods
The needle biopsy of liver of case 1 and samples of the liver from the necropsy of case 2 were routinely fixed in 10% buffered formalin and processed in paraffin wax. Four micron sections were stained with haematoxylin and eosin, periodic acid Schiff (PAS), Gordon and Sweets' reticulin, Masson's trichrome, Perls's Prussian blue and van Gieson stains.
Paraffin sections of both livers were examined by x-ray energy dispersive spectroscopy (XES), and, in case 1, by x-ray wavelength dispersive spectroscopy in a Jeol 35CF scanning electron microscope. Our methodology for x-ray spectroscopy of paraffin sections mounted on glass and perspex slides has been described in detail previously.4 Areas from both cases containing granular cells (described below), and adjacent tissues were analysed by XES at 25 kV for periods of 100 seconds. Identical XES techniques were applied to paraffin sections of two normal livers and to sections of liver from cases of Wilson's disease, haemochromatosis, and cryptogenic cirrhosis. Samples of a tablet and a capsule of amiodarone were examined by XES under the same conditions. To enable transmission electron microscopy (TEM) to be performed on the granular cells part of a glass mounted paraffin section was reprocessed for TEM by the method of Bretschneider et al. 5 It was viewed in a Jeol 2000 FX transmission electron microscope with XES attachment.
In an attempt to determine the precise histogenesis of the granular cells paraffin embedded sections of liver from both cases were stained by the peroxidase antiperoxidase (PAP) technique, following controlled trypsin digestion, using two monoclonal antibodies known to stain Kupffer cells and other macrophages, MAC 3876 and MT I (Eurodiagnostics), a monoclonal antibody to epithelial cytokeratin, CAM 5 2 (a gift of the ICRF), and a polyclonal antibody to a wider range of epithelial cytokeratins, keratin polyclonal PKE (Eurodiagnostics).
Results
The liver biopsy of case I showed preservation of the normal hepatic architecture. The main abnormality detected on light microscopy was the presence of focal collections of cells with swollen and granular cytoplasm (fig 1) , which appeared yellow or brown in haematoxylin and eosin stained sections. These foci of granular cells were associated with a mild increase in chronic inflammatory cells, mainly lymphocytes, and were predominantly grouped in a perivenular location (fig 1) . The granular pigment filled and distended 422 the iodine was only present in the distended lysosomes of the granular cells (fig 3) , and it was not detected elsewhere in these cells or in adjacent normal cells. XES analysis of the tablet and capsule of amiodarone produced a strong signal for iodine and only a weak signal for chlorine.
Discussion
Amiodarone is widely prescribed for refractory cardiac arrhythmias. Its use, however, is complicated by toxicity in several organs. Clinically apparent hepatotoxicity seems to be a relatively rare complication.2 A change in liver function tests, however, especially raised alkaline phosphatase and AST activities are more common.2 The drug has a very long half life, is known to be stored in the liver,7 and accumulation in the liver may result in increased density on computed tomography scan.8 Amiodarone is thought to induce a systemic metabolic abnormality in lysosomes, probably due to its amphophilic nature.9 It combines with the lipid of the lysosomal membrane to produce drug-lipid complexes that are recognised by electron microscopy as the lamellar lysosomal bodies which characterise amiodarone toxicity and that of other amphophilic drugs.3 These lamellar bodies are lysosomes greatly expanded by the phospholipidosis produced by the combination of the amphophilic drug and the lysosomal lipid.3
A range of histopathological abnormalities has been described in amiodarone hepatotoxicity.'0
Changes similar to those seen in alcoholic hepatitis, including steatosis, perivenular fibrosis, a heavy neutrophil infiltration, Mallory's hyaline, focal ballooning degeneration and focal necrosis have been reported.3 11-13 A portal mononuclear inflammatory infiltrate has been described, 13 -15 which may be associated with portal and periportal fibrosis. '5 Finally, micronodular cirrhosis, often with morphological changes similar to those seen in alcohol related liver disease, is recognised as a rare complication of amiodarone treatment. 3 12 16 In a large study of hepatic function during treatment with amiodarone by Harris etal7 15% of patients developed increased serum AST activities. There was a 1-5 to four-fold increase in the activities of this enzyme. Liver biopsies were performed in two patients who had increased enzyme activity. No changes attributable to amiodarone could be shown in either biopsy specimen. Perhaps the presence of granular cells in our case 1 represents a slightly more advanced stage of amiodarone hepatotoxicity than the two biopsied cases of these workers.
Whether the swollen granular cells are all macrophages or damaged hepatocytes remains uncertain. good presumptive evidence that they contained amiodarone or a metabolite of the drug. The high iodine content of amiodarone has been used clinically as a marker for the drug, and it is the iodine moiety of the drug that is known to accumulate in the various tissues.
" Lysosomal inclusions, mainly lamellar, have been previously described on electron microscopic examination of liver tissue in amiodarone heptotoxicity,3 9 1" 13 15 but they have not been analysed by XES. Varma et al'7 found such lysosomal bodies in two patients with mild increases in AST activity whose liver biopsy specimens were "essentially normal" although they do describe heptocytes with a finely granular cytoplasm.
A foamy appearance of cells on light microscopy corresponding to the lamellar inclusions at electron microscopy has been described in the alveoli of the lung.9 '9 Pulmonary fibrosis is a known complication of amiodarone, and cirrhosis of the liver is a rare complication of amiodarone treatment, as in our case 2 and in other case reports. 3 12 16 It is tempting to ascribe both pulmonary fibrosis and cirrhosis to the release of proteolytic enzymes from lysosomes disrupted by the phospholipidosis.
The lesions seen on light microscopy in case I are subtle and could easily be missed without very careful histological examination. We think it likely that these perivenular aggregates of granular cells represent the earliest morphological manifestation of amiodarone hepatotoxicity. Such changes are-probably important because: the main site of hepatocellular necrosis and fibrosis in amphophilic drug toxicity is also perivenular7; there is an inflammatory reaction associated with the granular cells; and, in case 2, the granular cells are also present as part of a progressive lesion. On withdrawal of amiodarone the hepatic function tests in case 1 became normal and the patient recovered completely. This suggests that the mor- 
